US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 17.860
  • -0.790-4.24%
Trading Nov 27 15:44 ET
453.91MMarket Cap-386P/E (TTM)

Cartesian Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cartesian Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.667M--
--2024/Q4-- / 133.330K--
--2024/Q3387.000K / 1.833M--
--2024/Q233.445M / 5.506M--
--2024/Q15.840M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 1.667M--
--2024/Q4-- / 133.330K--
--2024/Q3387.000K / 1.833M--
--2024/Q233.445M / 5.506M--
--2024/Q15.840M / 0.000--

Unlock Free Earnings Estimates

Cartesian Therapeutics Earnings Reports

  • Cartesian Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:23 ET

  • Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

    Nov 7 07:08 ET

  • Cartesian Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:09 ET

  • Cartesian Therapeutics | 8-K: Cartesian Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

    Aug 8 07:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 8, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data